These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 23364535

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
    Iwanaga K, Okada M, Murata T, Hori M, Ozaki H.
    J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tumor-associated stromal cells expressing E-prostanoid 2 or 3 receptors in prostate cancer: correlation with tumor aggressiveness and outcome by angiogenesis and lymphangiogenesis.
    Miyata Y, Ohba K, Matsuo T, Watanabe S, Hayashi T, Sakai H, Kanetake H.
    Urology; 2013 Jan; 81(1):136-42. PubMed ID: 23149328
    [Abstract] [Full Text] [Related]

  • 7. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway.
    Wang X, Klein RD.
    Mol Carcinog; 2007 Nov; 46(11):912-23. PubMed ID: 17427962
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Temporal and tissue-specific expression of prostaglandin receptors EP2, EP3, EP4, FP, and cyclooxygenases 1 and 2 in uterus and fetal membranes during bovine pregnancy.
    Arosh JA, Banu SK, Chapdelaine P, Fortier MA.
    Endocrinology; 2004 Jan; 145(1):407-17. PubMed ID: 14500566
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of prostaglandin E2 receptors (EP2, EP4) in the horse oviduct.
    Ball BA, Scoggin KE, Troedsson MH, Squires EL.
    Anim Reprod Sci; 2013 Nov 01; 142(1-2):35-41. PubMed ID: 24035156
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vivo intra-luteal implants of prostaglandin (PG) E1 or E2 (PGE1, PGE2) prevent luteolysis in cows. II: mRNA for PGF2α, EP1, EP2, EP3 (A-D), EP3A, EP3B, EP3C, EP3D, and EP4 prostanoid receptors in luteal tissue.
    Weems YS, Bridges PJ, Jeoung M, Arreguin-Arevalo JA, Nett TM, Vann RC, Ford SP, Lewis AW, Neuendorff DA, Welsh TH, Randel RD, Weems CW.
    Prostaglandins Other Lipid Mediat; 2012 Jan 01; 97(1-2):60-5. PubMed ID: 22120546
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1.
    Peng Y, Shi J, Du X, Wang L, Klocker H, Mo L, Mo Z, Zhang J.
    Int J Biochem Cell Biol; 2013 Mar 01; 45(3):521-30. PubMed ID: 23246486
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.